The Alliance for Artificial Intelligence in Healthcare (AAIH)

An exciting #WhatsUpWednesday from the AAIH! We are excited to spotlight Cytocast, an AAIH member making waves in AI-driven drug discovery with the launch of three new products: Screener, Optimizer, and Nominator! These tools are built to streamline and strengthen every stage of the preclinical pipeline - from early triage to lead selection - with interactive reports, smarter predictions, and insights to de-risk development. A big congrats to the Cytocast team for this innovation leap - and for their commitment to user-driven design and collaboration!

AI in Health Sciences is no longer just a concept - it is delivering measurable business impact! The AI in Health Sciences Playbook, published by the AAIH and our impactful members like C5i, is a strategic resource designed to help healthcare and pharma leaders harness AI for real-world value. Developed in collaboration with leading voices from industry and academia, this playbook equips C-suite leaders with the tools to: - Accelerate innovation across the R&D pipeline - Improve operational agility - Enhance engagement through intelligent, patient-centric insights Congratulations to all involved - and to the broader AAIH community — for delivering a roadmap that supports scalable, ethical, and impactful AI deployment in life sciences!

🚨 New White Paper Alert! 🚨 AI Model Trust & Compliance: Enabling Scalable and Responsible AI in Drug Discovery - Insights from the BiotechX Panel The healthcare industry has moved beyond asking if AI can add value. The real question now is: How do we deploy it responsibly, at scale, and with patient benefit in mind? At BiotechX 2025, the Alliance for Artificial Intelligence in Healthcare convened a forward-looking panel to explore what it takes to embed AI into real-world drug discovery and development workflows - moving beyond pilot projects to production systems that regulators, scientists, and patients can trust. Panelists included: Moderator Ahmet Hamdi C. (Merck Digital Sciences Studio), Caroline Farrell (Foley Hoag LLP), Jay Modh (Intuitive.Cloud), and Stacie Calad-Thomson, PhD (NVIDIA). Key Insights from the Discussion: - Trust must be designed in from the start - with clear context of use, regulatory alignment, data traceability, and wet-lab validation. - Strong programs prioritize measurable impact: faster INDs, fewer synthesized molecules, and auditable decision trails. - Compliance isn’t a blocker - it is an accelerator when built into daily operations. - Emerging collaboration models, like federated learning, are improving performance while preserving data privacy. This white paper distills the panel’s insights into actionable design principles, operating practices, and policy recommendations - offering a field-tested companion to the FDA’s conceptual guidance. Read the full white paper here: https://lnkd.in/eWRnj2BP

An exciting #WhatsUpWednesday this week from AAIH member C5i! C5i has been awarded with Minsky Awards for Excellence in AI 2025 at Cypher in the “Most Innovative Use of AI in Service Delivery” category, recognizing its role in advancing healthcare transformation.   Through its HLS Agentic Automation Project, C5i is reimagining service delivery across the pharmaceutical and healthcare sectors. Powered by Agent Hub, its in-house Agentic AI platform, the initiative has delivered measurable impact, including: - A 25–27% reduction in manual effort - 90% accuracy through human-in-the-loop processes - 2–3x greater coverage across therapeutic areas   As a member of The Alliance for Artificial Intelligence in Healthcare (AAIH), C5i plays an active role in advancing healthcare through innovation, accessibility, and ethical AI adoption. This collaboration reflects a joint commitment to harnessing AI in reshaping the future of healthcare and delivering meaningful impact across the industry.   Learn more about C5i's AI solutions for Life Sciences here: https://lnkd.in/gCcCHfEX

Last week at BioTechX Europe in Basel, the AAIH was proud to host a panel on AI in Clinical Trials - highlighting how AI is reshaping clinical development from design to execution. A big thank you to our expert panelists for sharing their perspectives, and to the BioTechX community for the thoughtful engagement. We are excited to continue driving conversations around the responsible and effective use of AI across the life sciences.

The Alliance for Artificial Intelligence in Healthcare is proud to see our Chair, Mustaqhusain Kazi, delivering the keynote at an exciting upcoming panel hosted by Bio-Rad Laboratories: “AI-Powered High-Throughput Discovery: From Assay to Insight” This event brings together leaders at the forefront of AI and life sciences innovation. Representing the AAIH mission to drive ethical, impactful use of AI in healthcare, Kazi will set the stage with a keynote on the transformative role of AI in discovery and development. Don’t miss this opportunity to hear how AI is reshaping the future of data-driven discovery.

AAIH Member Spotlight: Genialis For most cancers, physicians have a roadmap. For pancreatic cancer - especially PDAC - it is still generally guesswork. Genialis is working to change that. In partnership with Cleveland Clinic, Genialis is combining its Supermodel, trained on one of the largest and most diverse RNA-seq datasets, with patient-derived organoids to develop and validate AI-powered biomarkers for PDAC. The aim: better guidance for clinicians, and better outcomes for patients. This is the kind of impact-driven innovation the AAIH exists to support. #WhatsUpWednesday

It is Here: The AI in Health Sciences Playbook Has Launched! 95% of AI initiatives in health and life sciences fail to deliver ROI. In today’s market, that’s not just a missed opportunity - it is a fast track to irrelevance. Meanwhile, a select few are redefining the industry with AI strategies that actually work. The AI in Health Sciences Playbook is the C-suite's strategic guide to winning with AI in Pharma, Diagnostics, and Medtech - with actionable frameworks for value across the entire product lifecycle. Inside, you will learn how to: - Accelerate R&D - move from target to candidate in months, not years - Streamline Operations - reduce inventory costs by up to 20% and improve forecasting - Supercharge Commercialization - increase customer satisfaction by 30-40% through smarter engagement With expert contributions from: Mustaqhusain Kazi, Mary Birkel, Sukhveer Singh, Asif Mohammed, Mida Pezeshkian, Chandrasekhar Sharma, Abdullah Kazi, Stacie Calad-Thomson, PhD, Elaine H. The era of scattered AI experiments is over. This is your blueprint for competitive advantage. Read the full playbook: https://lnkd.in/e_x3cfEs

AAIH at BioTechX Europe: “How AI Models Are Being Used in Clinical Trials: Optimizing Trial Design and Accelerating Readouts by 12+ Months” Join the AAIH at BioTechX Europe for a forward-looking panel on how AI is reshaping clinical development - from preclinical modeling to late-stage trials and on-market strategy. 🗓 October 6, 2025 🕠 17:25 | Theater 10 📍 Basel, Switzerland Moderated by Rafael Rosengarten (Genialis), the panel features expert insights from Luca Finelli (Genentech), Felix Baldauf-Lenschen (Altis Labs), Szabolcs Nagy (Turbine), and Joseph Pearson (QIAGEN). Topics on the table include: - AI’s role from translational modeling to surrogate endpoints - Regulatory shifts like Project Optimus and FDA preferences - The build vs. buy debate in AI adoption - Data quality and the evolving challenge of defining ground truth - Plus: 5 key recommendations from our panelists on integrating AI into clinical strategy This is a conversation you won’t want to miss! #BioTechX #BioTechXEU #BioTechXEurope

In Case You Missed It: Highlights from the AI for Healthcare Campaign The AI for Healthcare campaign is making waves - and we are excited to see such positive engagement across the healthcare and AI communities! You won’t want to miss Elaine H., AAIH Executive Director, featured in the insightful article, “Why AI is Working, But Healthcare Infrastructure is Not.” Her perspective continues to spark important conversations around how AI can truly transform healthcare when paired with the right systems and infrastructure. Catch up on Elaine’s full article here: https://lnkd.in/e3SA9wB4